Robert Meguid
Concepts (396)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Postoperative Complications | 61 | 2025 | 2654 | 10.930 |
Why?
| | Esophagectomy | 18 | 2024 | 131 | 6.600 |
Why?
| | Esophageal Neoplasms | 21 | 2025 | 321 | 6.310 |
Why?
| | Surgical Procedures, Operative | 13 | 2025 | 259 | 5.580 |
Why?
| | Pneumonectomy | 11 | 2024 | 152 | 4.970 |
Why?
| | Surgeons | 10 | 2025 | 297 | 4.090 |
Why?
| | Thoracic Surgery | 8 | 2025 | 132 | 3.600 |
Why?
| | Quality Improvement | 24 | 2025 | 1178 | 3.210 |
Why?
| | Risk Assessment | 27 | 2024 | 3457 | 2.790 |
Why?
| | Robotic Surgical Procedures | 8 | 2025 | 130 | 2.730 |
Why?
| | Length of Stay | 13 | 2025 | 1215 | 2.480 |
Why?
| | Lung Neoplasms | 13 | 2025 | 2526 | 2.430 |
Why?
| | Retrospective Studies | 64 | 2025 | 15657 | 2.390 |
Why?
| | Inpatients | 5 | 2023 | 500 | 2.390 |
Why?
| | Preoperative Care | 7 | 2024 | 362 | 2.320 |
Why?
| | Databases, Factual | 22 | 2025 | 1357 | 2.230 |
Why?
| | Thoracic Surgical Procedures | 6 | 2025 | 73 | 2.200 |
Why?
| | Laparoscopy | 6 | 2024 | 466 | 2.170 |
Why?
| | Surgical Wound Infection | 7 | 2025 | 307 | 2.170 |
Why?
| | Ischemic Preconditioning | 4 | 2024 | 41 | 2.080 |
Why?
| | Urinary Tract Infections | 4 | 2022 | 188 | 1.850 |
Why?
| | Time-to-Treatment | 4 | 2025 | 205 | 1.830 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 7 | 2024 | 1081 | 1.810 |
Why?
| | Electronic Health Records | 7 | 2023 | 1069 | 1.770 |
Why?
| | Risk Factors | 34 | 2025 | 10388 | 1.750 |
Why?
| | Anastomosis, Surgical | 4 | 2024 | 153 | 1.730 |
Why?
| | Specialties, Surgical | 3 | 2023 | 75 | 1.610 |
Why?
| | Patient Readmission | 8 | 2025 | 697 | 1.610 |
Why?
| | Aged | 49 | 2025 | 23961 | 1.610 |
Why?
| | Middle Aged | 57 | 2025 | 33479 | 1.530 |
Why?
| | Humans | 131 | 2025 | 137585 | 1.530 |
Why?
| | Minimally Invasive Surgical Procedures | 6 | 2024 | 179 | 1.410 |
Why?
| | Hospital Mortality | 11 | 2022 | 911 | 1.360 |
Why?
| | Cardiac Surgical Procedures | 3 | 2025 | 530 | 1.330 |
Why?
| | Hospitals | 8 | 2025 | 691 | 1.330 |
Why?
| | United States | 37 | 2025 | 14841 | 1.280 |
Why?
| | Emergency Treatment | 2 | 2021 | 118 | 1.260 |
Why?
| | Sepsis | 4 | 2023 | 617 | 1.240 |
Why?
| | Informed Consent | 2 | 2020 | 175 | 1.200 |
Why?
| | Male | 67 | 2025 | 67762 | 1.140 |
Why?
| | Models, Statistical | 4 | 2020 | 669 | 1.100 |
Why?
| | Female | 65 | 2025 | 73304 | 1.090 |
Why?
| | Adenocarcinoma | 5 | 2024 | 940 | 1.090 |
Why?
| | Esophageal Stenosis | 2 | 2024 | 54 | 1.040 |
Why?
| | Intensive Care Units | 2 | 2022 | 827 | 1.020 |
Why?
| | Ambulatory Surgical Procedures | 2 | 2023 | 66 | 0.950 |
Why?
| | Guideline Adherence | 4 | 2024 | 556 | 0.950 |
Why?
| | Patient Discharge | 3 | 2020 | 897 | 0.910 |
Why?
| | Travel | 1 | 2025 | 130 | 0.870 |
Why?
| | Adult | 40 | 2025 | 37929 | 0.860 |
Why?
| | Lung Transplantation | 7 | 2023 | 313 | 0.850 |
Why?
| | Shock, Septic | 2 | 2023 | 219 | 0.840 |
Why?
| | Treatment Outcome | 21 | 2025 | 10811 | 0.830 |
Why?
| | Hypothermia | 1 | 2023 | 36 | 0.830 |
Why?
| | Hernia, Hiatal | 1 | 2023 | 35 | 0.820 |
Why?
| | Metastasectomy | 1 | 2023 | 20 | 0.820 |
Why?
| | Evidence-Based Practice | 2 | 2024 | 229 | 0.780 |
Why?
| | Logistic Models | 9 | 2023 | 2074 | 0.770 |
Why?
| | General Surgery | 4 | 2021 | 173 | 0.770 |
Why?
| | Seasons | 1 | 2025 | 547 | 0.750 |
Why?
| | Critical Pathways | 1 | 2022 | 96 | 0.720 |
Why?
| | Carcinoma, Pancreatic Ductal | 2 | 2023 | 289 | 0.700 |
Why?
| | Surgery Department, Hospital | 1 | 2020 | 20 | 0.680 |
Why?
| | Patient Admission | 1 | 2022 | 197 | 0.680 |
Why?
| | Neoplasm Staging | 7 | 2024 | 1389 | 0.670 |
Why?
| | Thoracic Surgery, Video-Assisted | 2 | 2019 | 43 | 0.660 |
Why?
| | Rectal Prolapse | 1 | 2020 | 23 | 0.640 |
Why?
| | Patient Satisfaction | 2 | 2022 | 660 | 0.630 |
Why?
| | Thoracotomy | 1 | 2019 | 75 | 0.620 |
Why?
| | Cohort Studies | 11 | 2023 | 5742 | 0.620 |
Why?
| | Anastomotic Leak | 4 | 2024 | 41 | 0.600 |
Why?
| | Venous Thromboembolism | 1 | 2023 | 316 | 0.600 |
Why?
| | Aftercare | 1 | 2020 | 208 | 0.590 |
Why?
| | Thoracoscopy | 2 | 2020 | 56 | 0.590 |
Why?
| | Outpatients | 1 | 2022 | 396 | 0.580 |
Why?
| | Hospitals, Teaching | 2 | 2009 | 118 | 0.580 |
Why?
| | Prognosis | 8 | 2024 | 4030 | 0.570 |
Why?
| | Patient Transfer | 2 | 2019 | 176 | 0.560 |
Why?
| | Time Factors | 10 | 2025 | 6828 | 0.540 |
Why?
| | Neoadjuvant Therapy | 4 | 2024 | 404 | 0.540 |
Why?
| | Morbidity | 4 | 2023 | 324 | 0.520 |
Why?
| | Stomach | 4 | 2024 | 110 | 0.520 |
Why?
| | Preoperative Period | 4 | 2021 | 129 | 0.520 |
Why?
| | Pancreatic Neoplasms | 2 | 2023 | 938 | 0.510 |
Why?
| | Survival Rate | 10 | 2024 | 1972 | 0.490 |
Why?
| | Tissue and Organ Procurement | 4 | 2023 | 321 | 0.470 |
Why?
| | Postoperative Care | 2 | 2016 | 261 | 0.470 |
Why?
| | Trachea | 1 | 2016 | 237 | 0.450 |
Why?
| | Data Collection | 1 | 2017 | 673 | 0.450 |
Why?
| | Intubation, Intratracheal | 1 | 2016 | 257 | 0.430 |
Why?
| | Physicians, Women | 2 | 2025 | 83 | 0.420 |
Why?
| | Constriction, Pathologic | 2 | 2024 | 245 | 0.400 |
Why?
| | Quality of Life | 2 | 2024 | 2892 | 0.390 |
Why?
| | Clinical Protocols | 2 | 2024 | 271 | 0.390 |
Why?
| | Machine Learning | 4 | 2023 | 493 | 0.380 |
Why?
| | Aortic Aneurysm, Abdominal | 3 | 2011 | 140 | 0.380 |
Why?
| | Emergencies | 2 | 2025 | 164 | 0.370 |
Why?
| | Societies, Medical | 3 | 2024 | 820 | 0.350 |
Why?
| | Prospective Studies | 6 | 2024 | 7604 | 0.340 |
Why?
| | Conversion to Open Surgery | 2 | 2020 | 16 | 0.340 |
Why?
| | Veterans | 1 | 2022 | 1476 | 0.330 |
Why?
| | Patient Reported Outcome Measures | 3 | 2024 | 402 | 0.330 |
Why?
| | Pregnancy Complications | 1 | 2015 | 527 | 0.330 |
Why?
| | Aged, 80 and over | 9 | 2023 | 7635 | 0.330 |
Why?
| | Thoracic Neoplasms | 2 | 2020 | 37 | 0.330 |
Why?
| | Pandemics | 5 | 2025 | 1639 | 0.320 |
Why?
| | Pain, Postoperative | 2 | 2023 | 265 | 0.310 |
Why?
| | Propensity Score | 3 | 2019 | 294 | 0.310 |
Why?
| | Aneurysm, Ruptured | 1 | 2009 | 35 | 0.300 |
Why?
| | Quality Assurance, Health Care | 3 | 2021 | 322 | 0.300 |
Why?
| | Incidence | 3 | 2025 | 2804 | 0.280 |
Why?
| | Triage | 2 | 2020 | 222 | 0.280 |
Why?
| | Disease-Free Survival | 3 | 2023 | 686 | 0.270 |
Why?
| | Reoperation | 2 | 2023 | 573 | 0.270 |
Why?
| | Pancreatic Diseases | 1 | 2008 | 72 | 0.270 |
Why?
| | Induction Chemotherapy | 2 | 2024 | 76 | 0.260 |
Why?
| | Pancreaticoduodenectomy | 1 | 2008 | 164 | 0.260 |
Why?
| | Chylothorax | 2 | 2017 | 16 | 0.260 |
Why?
| | Coronary Artery Bypass | 2 | 2025 | 234 | 0.260 |
Why?
| | Diaphragm | 2 | 2023 | 42 | 0.260 |
Why?
| | Reproducibility of Results | 3 | 2019 | 3284 | 0.250 |
Why?
| | Pneumonia | 2 | 2023 | 639 | 0.250 |
Why?
| | Colonic Neoplasms | 1 | 2008 | 258 | 0.250 |
Why?
| | Quality Indicators, Health Care | 2 | 2020 | 307 | 0.240 |
Why?
| | Chemoradiotherapy | 2 | 2024 | 225 | 0.240 |
Why?
| | Pancreatectomy | 1 | 2008 | 253 | 0.240 |
Why?
| | Follow-Up Studies | 5 | 2024 | 5131 | 0.230 |
Why?
| | Postoperative Hemorrhage | 2 | 2023 | 86 | 0.230 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 373 | 0.230 |
Why?
| | Coronavirus Infections | 2 | 2020 | 364 | 0.230 |
Why?
| | Case-Control Studies | 5 | 2024 | 3556 | 0.220 |
Why?
| | Practice Guidelines as Topic | 2 | 2024 | 1587 | 0.220 |
Why?
| | Spouses | 1 | 2025 | 105 | 0.210 |
Why?
| | Feasibility Studies | 2 | 2019 | 956 | 0.210 |
Why?
| | Respiratory Paralysis | 1 | 2023 | 3 | 0.210 |
Why?
| | Magnetic Resonance Imaging | 1 | 2015 | 3566 | 0.210 |
Why?
| | Smoking | 2 | 2012 | 1627 | 0.210 |
Why?
| | Comorbidity | 3 | 2022 | 1622 | 0.200 |
Why?
| | Mentors | 1 | 2025 | 202 | 0.200 |
Why?
| | Herniorrhaphy | 1 | 2023 | 60 | 0.200 |
Why?
| | Career Choice | 1 | 2025 | 219 | 0.200 |
Why?
| | Risk Adjustment | 1 | 2023 | 78 | 0.190 |
Why?
| | Algorithms | 3 | 2019 | 1704 | 0.190 |
Why?
| | Fluorouracil | 1 | 2023 | 208 | 0.190 |
Why?
| | Colorectal Surgery | 1 | 2022 | 24 | 0.190 |
Why?
| | Advisory Committees | 1 | 2023 | 219 | 0.190 |
Why?
| | Periodicals as Topic | 1 | 2024 | 211 | 0.180 |
Why?
| | Socioeconomic Factors | 2 | 2024 | 1289 | 0.180 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2023 | 1079 | 0.180 |
Why?
| | Databases as Topic | 1 | 2021 | 67 | 0.180 |
Why?
| | Heart Transplantation | 2 | 2023 | 754 | 0.180 |
Why?
| | Tissue Donors | 2 | 2023 | 425 | 0.170 |
Why?
| | Leadership | 1 | 2025 | 388 | 0.170 |
Why?
| | Focus Groups | 1 | 2023 | 522 | 0.170 |
Why?
| | Family | 1 | 2025 | 671 | 0.170 |
Why?
| | Lung | 2 | 2024 | 4060 | 0.170 |
Why?
| | Betacoronavirus | 2 | 2020 | 270 | 0.170 |
Why?
| | Arthroplasty | 1 | 2020 | 52 | 0.160 |
Why?
| | Fear | 1 | 2023 | 338 | 0.160 |
Why?
| | Robotics | 1 | 2021 | 94 | 0.160 |
Why?
| | Intermediate Care Facilities | 1 | 2019 | 3 | 0.160 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 1 | 1999 | 37 | 0.160 |
Why?
| | Benchmarking | 1 | 2021 | 186 | 0.160 |
Why?
| | Elective Surgical Procedures | 1 | 2021 | 179 | 0.160 |
Why?
| | Education, Medical, Graduate | 2 | 2017 | 486 | 0.150 |
Why?
| | Qualitative Research | 2 | 2025 | 1386 | 0.150 |
Why?
| | Glutamine | 1 | 1999 | 103 | 0.150 |
Why?
| | Physical Fitness | 1 | 2020 | 209 | 0.150 |
Why?
| | Geography | 1 | 2019 | 200 | 0.150 |
Why?
| | Digestive System Surgical Procedures | 1 | 2020 | 106 | 0.150 |
Why?
| | Datasets as Topic | 1 | 2019 | 121 | 0.150 |
Why?
| | Heat-Shock Proteins | 1 | 1999 | 143 | 0.150 |
Why?
| | Hospitals, University | 1 | 2018 | 182 | 0.150 |
Why?
| | Overweight | 1 | 2023 | 558 | 0.140 |
Why?
| | Skilled Nursing Facilities | 1 | 2019 | 141 | 0.140 |
Why?
| | Internship and Residency | 3 | 2021 | 1147 | 0.140 |
Why?
| | United States Department of Veterans Affairs | 1 | 2022 | 678 | 0.140 |
Why?
| | Forecasting | 1 | 2019 | 389 | 0.140 |
Why?
| | Medical Oncology | 1 | 2020 | 289 | 0.140 |
Why?
| | Altruism | 1 | 2017 | 27 | 0.140 |
Why?
| | Eating | 3 | 1995 | 380 | 0.140 |
Why?
| | Thoracic Wall | 1 | 2017 | 18 | 0.130 |
Why?
| | Models, Theoretical | 1 | 2021 | 578 | 0.130 |
Why?
| | Pylorus | 1 | 2017 | 18 | 0.130 |
Why?
| | Continuity of Patient Care | 1 | 2019 | 284 | 0.130 |
Why?
| | Gastric Outlet Obstruction | 1 | 2017 | 12 | 0.130 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2020 | 261 | 0.130 |
Why?
| | Self Efficacy | 1 | 2020 | 396 | 0.130 |
Why?
| | Medically Underserved Area | 1 | 2017 | 85 | 0.130 |
Why?
| | Soft Tissue Infections | 1 | 2017 | 37 | 0.130 |
Why?
| | Pain Management | 1 | 2020 | 352 | 0.130 |
Why?
| | Pleural Effusion | 1 | 2017 | 54 | 0.130 |
Why?
| | Parenteral Nutrition | 2 | 1995 | 107 | 0.130 |
Why?
| | Abscess | 1 | 2017 | 75 | 0.130 |
Why?
| | Clinical Competence | 3 | 2021 | 1118 | 0.130 |
Why?
| | Frailty | 1 | 2019 | 170 | 0.130 |
Why?
| | Neuromuscular Agents | 1 | 2017 | 35 | 0.130 |
Why?
| | Botulinum Toxins, Type A | 1 | 2017 | 45 | 0.120 |
Why?
| | Postoperative Period | 4 | 2021 | 342 | 0.120 |
Why?
| | Home Care Services | 1 | 2019 | 257 | 0.120 |
Why?
| | Chyle | 1 | 2015 | 4 | 0.120 |
Why?
| | Multivariate Analysis | 1 | 2019 | 1509 | 0.120 |
Why?
| | Prevalence | 1 | 2022 | 2734 | 0.120 |
Why?
| | Health Status | 1 | 2021 | 792 | 0.120 |
Why?
| | Nutritional Support | 1 | 2015 | 34 | 0.120 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2024 | 1692 | 0.120 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2019 | 301 | 0.120 |
Why?
| | Monitoring, Intraoperative | 1 | 2015 | 56 | 0.120 |
Why?
| | Factor Analysis, Statistical | 1 | 2016 | 283 | 0.120 |
Why?
| | Osteomyelitis | 1 | 2017 | 132 | 0.120 |
Why?
| | Orthopedics | 1 | 2017 | 144 | 0.120 |
Why?
| | Altitude | 1 | 2019 | 488 | 0.110 |
Why?
| | Patient-Centered Care | 1 | 2020 | 530 | 0.110 |
Why?
| | Environmental Exposure | 1 | 2019 | 579 | 0.110 |
Why?
| | Biomedical Research | 1 | 2021 | 692 | 0.110 |
Why?
| | Radiosurgery | 1 | 2018 | 344 | 0.110 |
Why?
| | Body Mass Index | 1 | 2023 | 2389 | 0.110 |
Why?
| | Hypotension | 1 | 2015 | 122 | 0.110 |
Why?
| | Proportional Hazards Models | 3 | 2018 | 1266 | 0.110 |
Why?
| | Hospitals, Veterans | 1 | 2015 | 252 | 0.110 |
Why?
| | Sensitivity and Specificity | 1 | 2018 | 1946 | 0.110 |
Why?
| | Colorado | 3 | 2018 | 4565 | 0.110 |
Why?
| | Healthcare Disparities | 1 | 2020 | 654 | 0.110 |
Why?
| | Health Services Research | 1 | 2016 | 404 | 0.100 |
Why?
| | Hospitalization | 2 | 2021 | 2199 | 0.100 |
Why?
| | Research Design | 1 | 2020 | 1139 | 0.100 |
Why?
| | Proteins | 1 | 1999 | 1009 | 0.100 |
Why?
| | Age Factors | 1 | 2021 | 3295 | 0.100 |
Why?
| | Esophagogastric Junction | 2 | 2024 | 51 | 0.100 |
Why?
| | Leiomyosarcoma | 1 | 2012 | 28 | 0.100 |
Why?
| | Decision Making | 1 | 2020 | 900 | 0.100 |
Why?
| | Pulmonary Emphysema | 1 | 2015 | 288 | 0.100 |
Why?
| | Heart Neoplasms | 1 | 2012 | 50 | 0.100 |
Why?
| | RNA, Messenger | 2 | 1999 | 2833 | 0.100 |
Why?
| | Arterial Occlusive Diseases | 1 | 2012 | 83 | 0.100 |
Why?
| | DNA-Binding Proteins | 1 | 1999 | 1502 | 0.090 |
Why?
| | Energy Intake | 1 | 1995 | 485 | 0.090 |
Why?
| | Endoleak | 1 | 2011 | 17 | 0.090 |
Why?
| | Duodenal Diseases | 1 | 2011 | 8 | 0.090 |
Why?
| | Intestinal Fistula | 1 | 2011 | 17 | 0.090 |
Why?
| | Surveys and Questionnaires | 2 | 2025 | 5778 | 0.090 |
Why?
| | Practice Patterns, Physicians' | 1 | 2020 | 1313 | 0.090 |
Why?
| | Transcription Factors | 1 | 1999 | 1719 | 0.090 |
Why?
| | Heart Valve Diseases | 1 | 2012 | 151 | 0.090 |
Why?
| | Pulmonary Valve | 1 | 2012 | 97 | 0.090 |
Why?
| | Body Composition | 1 | 1995 | 684 | 0.090 |
Why?
| | Transplant Recipients | 2 | 2023 | 184 | 0.080 |
Why?
| | Adipose Tissue | 1 | 1995 | 635 | 0.080 |
Why?
| | Aortic Diseases | 1 | 2011 | 119 | 0.080 |
Why?
| | Hospitals, District | 1 | 2009 | 6 | 0.080 |
Why?
| | Obesity | 1 | 2023 | 2992 | 0.080 |
Why?
| | Pancreas, Exocrine | 1 | 2008 | 7 | 0.080 |
Why?
| | Longitudinal Studies | 2 | 2024 | 2844 | 0.080 |
Why?
| | Chi-Square Distribution | 1 | 2009 | 530 | 0.070 |
Why?
| | Patient Selection | 3 | 2020 | 696 | 0.070 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2008 | 267 | 0.070 |
Why?
| | SEER Program | 1 | 2008 | 227 | 0.070 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2015 | 1040 | 0.070 |
Why?
| | Precancerous Conditions | 1 | 2008 | 169 | 0.070 |
Why?
| | Neoplasm Metastasis | 1 | 2009 | 658 | 0.070 |
Why?
| | Lymphatic Metastasis | 1 | 2008 | 352 | 0.070 |
Why?
| | Consensus | 2 | 2020 | 683 | 0.070 |
Why?
| | Pulmonary Artery | 1 | 2012 | 1086 | 0.060 |
Why?
| | Neoplasm Invasiveness | 1 | 2008 | 510 | 0.060 |
Why?
| | Cause of Death | 1 | 2008 | 434 | 0.060 |
Why?
| | Vascular Surgical Procedures | 1 | 2009 | 303 | 0.060 |
Why?
| | Hypertension | 1 | 2015 | 1295 | 0.060 |
Why?
| | Evidence-Based Medicine | 1 | 2009 | 740 | 0.060 |
Why?
| | Graft Survival | 2 | 2023 | 535 | 0.060 |
Why?
| | Glypicans | 1 | 2023 | 11 | 0.050 |
Why?
| | Kaplan-Meier Estimate | 2 | 2019 | 889 | 0.050 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2025 | 130 | 0.050 |
Why?
| | Diagnostic Tests, Routine | 1 | 2024 | 110 | 0.050 |
Why?
| | Triglycerides | 2 | 2015 | 524 | 0.050 |
Why?
| | Pregnancy | 1 | 2015 | 6763 | 0.050 |
Why?
| | Odds Ratio | 2 | 2019 | 1070 | 0.050 |
Why?
| | Interpersonal Relations | 1 | 2025 | 397 | 0.050 |
Why?
| | Colectomy | 1 | 2022 | 100 | 0.040 |
Why?
| | Registries | 2 | 2025 | 2035 | 0.040 |
Why?
| | Dyspnea | 1 | 2023 | 254 | 0.040 |
Why?
| | Neurosurgical Procedures | 1 | 2023 | 197 | 0.040 |
Why?
| | Fatigue | 1 | 2023 | 329 | 0.040 |
Why?
| | Tumor Cells, Cultured | 2 | 1999 | 955 | 0.040 |
Why?
| | Learning Curve | 1 | 2021 | 72 | 0.040 |
Why?
| | Adolescent | 3 | 2023 | 21513 | 0.040 |
Why?
| | Professional Practice Gaps | 1 | 2020 | 15 | 0.040 |
Why?
| | Comparative Effectiveness Research | 1 | 2021 | 152 | 0.040 |
Why?
| | Child | 1 | 2020 | 21935 | 0.040 |
Why?
| | Glutaminase | 1 | 1999 | 11 | 0.040 |
Why?
| | Transcription Factor CHOP | 1 | 1999 | 31 | 0.040 |
Why?
| | Predictive Value of Tests | 2 | 2019 | 2031 | 0.040 |
Why?
| | Margins of Excision | 1 | 2019 | 50 | 0.040 |
Why?
| | Hydrolysis | 1 | 1999 | 177 | 0.040 |
Why?
| | Walk Test | 1 | 2019 | 76 | 0.040 |
Why?
| | Serum Albumin | 1 | 2019 | 150 | 0.040 |
Why?
| | Confidence Intervals | 2 | 2009 | 329 | 0.040 |
Why?
| | Health Services Needs and Demand | 1 | 2020 | 273 | 0.040 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2023 | 801 | 0.040 |
Why?
| | Sarcopenia | 1 | 2019 | 83 | 0.040 |
Why?
| | Molecular Chaperones | 1 | 1999 | 195 | 0.030 |
Why?
| | ROC Curve | 1 | 2019 | 554 | 0.030 |
Why?
| | Cell Division | 1 | 1999 | 794 | 0.030 |
Why?
| | Needs Assessment | 1 | 2020 | 376 | 0.030 |
Why?
| | Alternative Splicing | 1 | 1999 | 229 | 0.030 |
Why?
| | Occupational Health | 1 | 2020 | 200 | 0.030 |
Why?
| | Negative-Pressure Wound Therapy | 1 | 2017 | 27 | 0.030 |
Why?
| | Activities of Daily Living | 1 | 2020 | 413 | 0.030 |
Why?
| | Clinical Decision-Making | 1 | 2020 | 322 | 0.030 |
Why?
| | HIV Infections | 1 | 2012 | 2836 | 0.030 |
Why?
| | Cell Line | 2 | 1999 | 2847 | 0.030 |
Why?
| | Clinical Audit | 1 | 2016 | 14 | 0.030 |
Why?
| | Education | 1 | 2017 | 108 | 0.030 |
Why?
| | Regression Analysis | 1 | 2019 | 1024 | 0.030 |
Why?
| | Gastric Emptying | 1 | 2017 | 38 | 0.030 |
Why?
| | Competency-Based Education | 1 | 2017 | 73 | 0.030 |
Why?
| | Lymph Nodes | 1 | 2019 | 491 | 0.030 |
Why?
| | Patient Safety | 1 | 2020 | 314 | 0.030 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 1999 | 455 | 0.030 |
Why?
| | Cadaver | 1 | 2017 | 296 | 0.030 |
Why?
| | Operative Time | 1 | 2016 | 145 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2023 | 2475 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2023 | 3412 | 0.030 |
Why?
| | Electrolytes | 1 | 2015 | 58 | 0.030 |
Why?
| | Dietary Fiber | 1 | 2015 | 54 | 0.030 |
Why?
| | Carrier Proteins | 1 | 1999 | 771 | 0.030 |
Why?
| | Infection Control | 1 | 2016 | 167 | 0.030 |
Why?
| | Pilot Projects | 1 | 2020 | 1710 | 0.030 |
Why?
| | Micronutrients | 1 | 2015 | 92 | 0.030 |
Why?
| | Blood Pressure Determination | 1 | 2015 | 157 | 0.030 |
Why?
| | Dietary Proteins | 1 | 2015 | 135 | 0.030 |
Why?
| | Apoptosis | 1 | 2023 | 2553 | 0.030 |
Why?
| | Fatty Acids, Nonesterified | 1 | 1995 | 159 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2017 | 1236 | 0.030 |
Why?
| | Glycogen | 1 | 1993 | 55 | 0.030 |
Why?
| | Poverty | 1 | 2017 | 521 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2025 | 5472 | 0.030 |
Why?
| | Dietary Fats | 1 | 2015 | 304 | 0.030 |
Why?
| | Rats | 4 | 1995 | 5647 | 0.030 |
Why?
| | Transcription, Genetic | 1 | 1999 | 1457 | 0.030 |
Why?
| | Mortality | 1 | 2015 | 362 | 0.020 |
Why?
| | Staphylococcus epidermidis | 1 | 1993 | 77 | 0.020 |
Why?
| | Echocardiography, Transesophageal | 1 | 2012 | 96 | 0.020 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2012 | 145 | 0.020 |
Why?
| | Maryland | 1 | 2012 | 60 | 0.020 |
Why?
| | Analgesics, Opioid | 1 | 2020 | 1000 | 0.020 |
Why?
| | Pulmonary Diffusing Capacity | 1 | 2012 | 75 | 0.020 |
Why?
| | Anesthesia, General | 1 | 1992 | 77 | 0.020 |
Why?
| | Carbon Monoxide | 1 | 2012 | 81 | 0.020 |
Why?
| | Catheterization, Central Venous | 1 | 1993 | 112 | 0.020 |
Why?
| | Disease Management | 1 | 2015 | 628 | 0.020 |
Why?
| | Peritonitis | 1 | 2011 | 84 | 0.020 |
Why?
| | Chronic Disease | 1 | 2017 | 1793 | 0.020 |
Why?
| | Body Weight | 1 | 1995 | 985 | 0.020 |
Why?
| | Endoscopy, Digestive System | 1 | 2011 | 136 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 1995 | 2486 | 0.020 |
Why?
| | Blood Vessel Prosthesis Implantation | 1 | 2011 | 202 | 0.020 |
Why?
| | Rats, Inbred F344 | 3 | 1993 | 265 | 0.020 |
Why?
| | Staphylococcal Infections | 1 | 1993 | 400 | 0.020 |
Why?
| | Wounds and Injuries | 1 | 2015 | 758 | 0.020 |
Why?
| | California | 1 | 2009 | 431 | 0.020 |
Why?
| | Receptors, Notch | 1 | 2008 | 88 | 0.020 |
Why?
| | Safety | 1 | 2009 | 338 | 0.020 |
Why?
| | Transplantation, Homologous | 1 | 2008 | 416 | 0.020 |
Why?
| | Endovascular Procedures | 1 | 2011 | 312 | 0.020 |
Why?
| | Breast Neoplasms | 1 | 1999 | 2253 | 0.020 |
Why?
| | Liver | 1 | 1995 | 1943 | 0.020 |
Why?
| | Cost-Benefit Analysis | 1 | 2008 | 591 | 0.020 |
Why?
| | Academic Medical Centers | 1 | 2008 | 512 | 0.010 |
Why?
| | Graft Rejection | 1 | 2008 | 624 | 0.010 |
Why?
| | Animals | 5 | 2008 | 36940 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2008 | 1250 | 0.010 |
Why?
| | Young Adult | 1 | 2020 | 13209 | 0.010 |
Why?
| | Mice, Transgenic | 1 | 2008 | 2167 | 0.010 |
Why?
| | Brain | 1 | 1993 | 2668 | 0.010 |
Why?
| | Blotting, Northern | 1 | 1999 | 201 | 0.010 |
Why?
| | DNA, Complementary | 1 | 1999 | 272 | 0.010 |
Why?
| | Tissue Distribution | 1 | 1999 | 332 | 0.010 |
Why?
| | Sequence Alignment | 1 | 1999 | 343 | 0.010 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1999 | 385 | 0.010 |
Why?
| | Isoenzymes | 1 | 1999 | 304 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 1999 | 534 | 0.010 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 1999 | 283 | 0.010 |
Why?
| | Sequence Analysis, DNA | 1 | 1999 | 812 | 0.010 |
Why?
| | Base Sequence | 1 | 1999 | 2181 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 1999 | 2139 | 0.010 |
Why?
| | Signal Transduction | 1 | 2008 | 5079 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 1999 | 2900 | 0.010 |
Why?
| | Osmolar Concentration | 1 | 1993 | 171 | 0.010 |
Why?
| | Chloral Hydrate | 1 | 1992 | 3 | 0.010 |
Why?
| | Periodicity | 1 | 1992 | 58 | 0.010 |
Why?
| | Organ Specificity | 1 | 1993 | 305 | 0.010 |
Why?
| | Leukocyte Count | 1 | 1993 | 329 | 0.010 |
Why?
| | Mice | 1 | 2008 | 17787 | 0.010 |
Why?
| | Food Preferences | 1 | 1992 | 119 | 0.010 |
Why?
| | Circadian Rhythm | 1 | 1992 | 468 | 0.000 |
Why?
| | Disease Models, Animal | 1 | 1993 | 4295 | 0.000 |
Why?
|
|
Meguid's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|